Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Transgene discloses phase IIb data for TG-4010

May 30, 2014

Clinical evaluation of a dendritic cell-targeting vaccine for the treatment of refractory tumors

May 30, 2014

BMS and Incyte initiate phase I/II immunotherapy combination trial in cancer

May 29, 2014

Ganymed reports results from phase IIa gastroesophageal cancer trial

May 28, 2014

FDA grants orphan drug designation to Advaxis' ADXS-cHER2 for osteosarcoma

May 28, 2014

FDA grants orphan drug status to SAR-650984 for cancer

May 28, 2014

Cel-Sci expands phase III study of Multikine to new U.S. site

May 28, 2014

BioInvent sells back ADC-1013 rights to Alligator Bioscience

May 28, 2014

European researchers disclose new anti-S100-A4 MAbs

May 27, 2014

Daiichi Sankyo receives additional indication approval in Japan for Ranmark

May 27, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026